Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
Health & Fitness
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
AAdmin
October 27, 2026
1 min read
